RIDGE Trademark
Trademark Overview
On Thursday, April 6, 2023, a trademark application was filed for RIDGE with the United States Patent and Trademark Office. The USPTO has given the RIDGE trademark a serial number of 97876248. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 21, 2024. This trademark is owned by Tenaya Therapeutics, Inc.. The RIDGE trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Business consulting and business project management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes and business management of clinical trial execution by providing independent review of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, business management of clinical trial execution; providing technical business and marketing consulting services in the field of marketing and advertising for clinical trials, verifying clinical trial subject eligibility for clinical trials of others, clinical trial subject recruitment and enrollment for clinical trials of others, and processing business documents relating to clinical trials, and information management services; data management services for use in managing cl...
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Providing information on clinical studies via an interactive website; Consulting services for others in the field of design, planning, and implementation project management of clinical trials
General Information
Serial Number | 97876248 |
Word Mark | RIDGE |
Filing Date | Thursday, April 6, 2023 |
Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
Status Date | Tuesday, May 21, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, March 26, 2024 |
Trademark Statements
Goods and Services | Business consulting and business project management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes and business management of clinical trial execution by providing independent review of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, business management of clinical trial execution; providing technical business and marketing consulting services in the field of marketing and advertising for clinical trials, verifying clinical trial subject eligibility for clinical trials of others, clinical trial subject recruitment and enrollment for clinical trials of others, and processing business documents relating to clinical trials, and information management services; data management services for use in managing clinical data, provided to medical, pharmaceutical and technology companies in order to assist them with clinical research, clinical trials and applications for drug approval; compilation of statistics and clinical trial data for business purposes; statistical analysis for business purposes; preparing and placing advertisements for others, namely, to recruit subjects for participation in clinical trials; providing referrals of subjects for enrollment in clinical trials |
Goods and Services | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Providing information on clinical studies via an interactive website; Consulting services for others in the field of design, planning, and implementation project management of clinical trials |
Classification Information
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Monday, May 1, 2023 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, May 1, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Tenaya Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | South San Francisco, CA 94080 |
Party Name | Tenaya Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | South San Francisco, CA 94080 |
Trademark Events
Event Date | Event Description |
Monday, April 10, 2023 | NEW APPLICATION ENTERED |
Monday, May 1, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, January 2, 2024 | ASSIGNED TO EXAMINER |
Thursday, January 4, 2024 | NON-FINAL ACTION WRITTEN |
Thursday, January 4, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, January 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, February 7, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, February 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, February 8, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, February 21, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, March 6, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, March 6, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, March 26, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, March 26, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, May 21, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Friday, November 15, 2024 | SOU TEAS EXTENSION RECEIVED |